numerous side effects and evidence a weak ability to block and even to reverse AD, acting only on clinical symptoms, but not on causal factors or prevention.
Botanical preparations are a complex pool of phytochemicals, being their ethnopharmacological potential mainly conferred by secondary metabolites (Spencer et al. 2012 ). Particularly to AD, a multitude of studies have shown that they act as prominent brain health improvers, being useful not only to prevent but also to block and even avert neurological dysfunctions (Marco and Carreiras 2006; Essa et al. 2012; Smid et al. 2012; Spencer et al. 2012; Konrath et al. 2013; Ahmed et al. 2015) . Furthermore, it is convenient to highlight that the majority of chemical drugs are plant-derived mimetic; notwithstanding, in the whole plant, different proportions of phytochemicals, their synergisms, antagonisms, and polyvalent reactions improve the bioactive potential and also block some harmful substances.
Apart from those aspects, a correct and active lifestyle, which includes physical and intellectual activity, and balanced diet are also well-established aspects that provide important benefits to preserve, improve, and even block memory and cognition impairment (van Praag 2009; Murray and Pizzorno 2012) . Regarding dietary aspects, not only correct food choices, but also nutritional supplementation confers prominent influences. Functional foods and nutraceuticals have the ability to act as bioactives by simply enriching daily diet (Murray and Pizzorno 2005, 2012) . Overall, the use of plant-derived preparations, as part of a healthy lifestyle, might have a great impact on life expectancy and health improvement.
3 Plant-Food-Based Formulations: An Integrative Approach Natural matrices are an extremely rich source of bioactive molecules. Through photosynthesis, numerous organic compounds mainly derived from primary (lipids, proteins, carbohydrates, and chlorophyll) and secondary (such as, terpenes, steroids, alkaloids, and phenolic compounds) metabolites are daily produced by higher plants (Nelson and Cox 2000) . They possess crucial biological functions, most of them related to their proper survival, optimum growth, nutrition, and protection against invaders (Nelson and Cox 2000) . Notwithstanding, increasing evidences confirm phytochemical, human health benefits, when integrated as part of daily routine (Cowan 1999; Fernandez-Panchon et al. 2008; Kaushik et al. 2010; Goodman et al. 2011) . Several plant-derived preparations can be used according to the final biological potential and/or selected phytochemical(s). For example, berries (such as blueberry, cranberry, bilberry, grapes, barberry, and strawberry) have been related to antiaging benefits, mainly due to their richness in phenolic compounds, including anthocyanins (Larrosa et al. 2010; Tulipani et al. 2011; Hoggard et al. 2013; Norberto et al. 2013; McKay et al. 2015) . They can be directly consumed as fresh fruits, or even through infusions/decoctions, capsules, drops, and extracts, among others.
Despite the health-improving effects, the abundance of bioactive compounds in those matrices is doubtless different, and therefore, the final phytopharmacological potential will considerably vary. Apart from this aspect, the bioavailability and related bioefficacy of plant phytochemical preparations will also differ (Holst and Williamson 2008; Rein et al. 2013; Velderrain-Rodríguez et al. 2014) . It means that despite the promissory bioactive properties of numerous natural products, it is important to select the most adequate extraction solvent, binomial time/temperature, or type of formulation/preparation, according to each specific finality. All of the stated premises assume that those products are correctly controlled in order to possess the higher abundance in bioactive constituents.
Regarding plant-derived phytochemicals with documented in vitro and in vivo neuroprotective (Tables 1, 2, 3, 4, 5, 6 and 7) and neuroregenerative (Figs. 1, 2, 3, 4 and 5) effects, methanol (MeOH), water (H 2 O), ethanol (EtOH), and mixtures of the previous (MeOH: H 2 O; EtOH: H 2 O) extraction solvents, in different proportions, are amongst to the most commonly used extraction solvents. Dichloromethane (DCM), ethyl acetate (EtOAc), n-butanol, chloroform, and DCM: MeOH have also been sporadically used, mainly for alkaloid, terpene, and saponin extraction.
It is convenient to highlight that the use of solvent mixtures, such as MeOH: H 2 O, has been increasingly adopted. In fact, recent studies show that specific proportions of solvent mixtures improve the efficiency of extraction and consequently the richness on bioactive molecules in the final extract.
Plant Food Bioactive Molecules with Neuroprotective Activity

Bioactive Compounds with In Vitro Neuroprotective Activity
Commercial Molecules
Tables 1 and 2 show the major groups of compounds from commercial origin with reported in vitro neuroprotective effects. Among phenolic compounds (Table 1) , flavan-3-ols, flavones, flavonols, isoflavones, lignans, phenolic acids, and stilbenes comprise the most common classes. Quercetin (a flavonol), followed by myricetin (a flavonol) and kaempferol (a flavonol), and then apigenin (flavone), baicalein (flavone), catechin (flavan-3-ols), and EGCG (flavan-3-ols) are the most studied phenolic compounds. In particular, quercetin has shown several neuroprotective effects, being its ability to reduce and/or to prevent reactive oxygen species (ROS) overproduction amongst to the most prominent; its active concentrations varied significantly according to the model used, but interestingly, as described by Vepsäläinen et al. (2013) , at 0.5, 2.5, and 10 µM a, pronounced reduction in ROS overproduction was observed in human SH-SY5Y neuroblastoma cells (with menadione as oxidative stress inducer).
In the same line, myricetin also evidenced a similar potential, being together with quercetin the flavonols with the highest in vitro potential. Two phenolic acids (ferulic acid and p-coumaric acid) and the flavonol (kaempferol) also showed interesting effects, directly related to their potent antioxidant activity. The active concentrations were 1.563-12.5 lM (ferulic acid), 5, 25, 50 lM (p-coumaric acid), and 3-30 lM (kaempferol). Other phenolic acids, such as rosmarinic (23.6 lM) and 3,5-di-caffeoylquinic (20 lM) acids, also evidenced significant effects, followed by the flavan-3-ols (catechin, EGCG, and epicatechin) and the flavones (apigenin, baicalein, and luteolin), which were effective at 30 lM. On the other hand, the flavones (morin and scutellarein), the flavonol fisetin, the isoflavone genistein, the lignan NDGA, and, lastly, the stilbene resveratrol were only effective at 50 lM. Finally, caffeic and chlorogenic acids proved to be the least effective, once the active concentrations were 118 lM and 2000 lM, respectively, which correspond to the IC 50 values.
By comparing the in vitro neuroprotective effects of phenolic compounds with other bioactive non-phenolic compounds (Table 2) , it is clearly evident that the first ones evidenced a greater effect, mainly the flavonols (quercetin and myricetin), being highly effective at lower doses. It is particularly convenient to highlight the effect of the following terpenes: hyperforin (1 lM), ursolic acid (1, 10, 20 lM), and asiatic acid (10 lM) which presented the most prominent activity at lower concentrations. Salidroside, a glycoside, several quinones (1,4-benzoquinone, 1,4-naphthoquinone, 9,10-anthraquinone, 9,10-phenanthraquinone, aloe-emodin, chrysophanol, and emodin), the terpenes (carnosic acid and ginkgolide B), and lastly purpurogallin trimethyl ether and rhein evidenced similar effects to those of phenolic compounds, which were effective at 50 lM.
Overall, the phenolic compounds seem to present more significant in vitro neuroprotective effects than non-phenolic molecules, which might be attributed to their Th-T assay Thioflavin-T assay; LPS lipopolysaccharide higher antioxidant potential, namely as free radical scavengers and also as metal quenchers and hydrogen donators (Heim et al. 2002; Grotewold 2006; Li et al. 2014 ).
Plant-Food-Derived Molecules
Tables 3, 4 and 5 show the in vitro neuroprotective effects of plant-origin phenolic and non-phenolic molecules.
In relation to phenolic compounds (Table 3) , isoflavones, such as 5,7,4′tryhydroxy-6,3′-diprenyllisoflavone (4.47 lM) and osajin (5.01 lM) obtained from Flemingia macrophylla L., gave the most promissory effects, followed by the lignan, olivil-4′-O-b-D-glucopyranoside (5; 12.5; 25 lM) and (+) pinoresinol-4-4′-di-O-b-D-glucopyranoside (5; 12; 25 lM), both obtained from Valeriana amurensis P. Smirn. ex. Kom., and, lastly, the phenolic acid, rosmarinic acid (5; 15; 25 lM), from Rosmarinus officinalis L.
Despite the scarce results on in vitro neuroprotective effects of non-phenolic compounds (Table 4) , when compared with the first ones, they evidence a higher 
Kitag.
Roots
Amnesic mice scopolamine-induced 50 mg/kg b. w. Weon et al. (2013) and more promissory effect. Coumarins obtained from the rhizomes of Eleutherococcus senticosus (Rupr. Et Maxim.) Maxim., namely isofraxidin and isofraxidin 7-O-glucoside, and also saponins, which include stigmasterol 3-O-b-Dglucopyranoside and eleutheroside E and B, exert a higher effect than phenolic compounds. Its active concentrations were for both coumarins and saponins, 1 and 10 lM.
Several terpenes, such as spirafolide (5.7 lM) from the leaves of Laurus nobilis L., and others obtained from the rhizomes and roots of Valeriana amurensis were also effective at lower concentrations (5; 12; 25 lM), being able to reduce apoptosis in human neuroblastoma cells and PC12 cells.
The bioactive constituent, (3R) 1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol, obtained from Curcuma comosa Roxb., was highly effective (0.1; 0.5; 1 lM) (Table 5) , being able to reduce lipopolysaccharide (LPS)-induced NO and PGE 2 production, in a dose-dependent manner. Furthermore, the active concentrations Fig. 1 Overview of the in vitro neuroregenerative effects of specific phytochemicals. Legend: BDNF brain-derived neurotrophic factor; ERK extracellular signal-regulated kinase; CREB cyclic AMP response element-binding protein; iNOS inducible nitric oxide synthase. The effects were observed by using the concentrations 0.1, 0.3, and 1 µM of each one of the tested compounds in cerebral cells from the cortex of fetal Sprague-Dawley rats (Jeon et al. 2010) were also able to reduce inducible NO synthase and cyclooxygenase 2 (COX-2). Similarly, b-sitosterol 3-O-b-D-glucopyranoside (1; 10 lM) obtained from the rhizomes of Eleutherococcus senticosus strongly inhibited neuritic atrophy induced Legend Effects of flavonoids on the mitochondrial function were assessed by using 1 µM of each one in murine neuroblastoma N2a cells, and then, measure its activity at a level of ROS production, MMP and ATP levels (Dragicevic et al. 2011) ; evaluation of Ab production was assessed by using 50 µM of each one of the tested compounds in CHO 2B7 cells (Chen et al. 2006) by Ab 25-35 , being clearly evident its protective effects against cognitive and memory impairments. 2,3-Dihydroxy-4-methoxyacetophenone (10.94 lM), isolated from the roots of Cynanchum paniculatum (Bunge), also evidenced a pronounced effect against neuronal damage and toxicity, in HT22 cells, induced by glutamate.
Overall, and comparing the efficacy and efficiency of the studied bioactive molecules in relation to its sources (commercial vs. plant origin), it is possible to conclude that plant-origin bioactive compounds possess a doubtless prominent potential. Although some of them were not studied and then compared from both sources, several examples should be highlighted. While for luteolin, derived from commercial (30 lM) and plant (30, 40, and 50 lM) sources, similar active concentrations were found, for rosmarinic acid a completely different situation was observed; the commercial molecule was effective at 23.5-50 lM, while the one from plant origin was effective at 5, 15, and 25 lM. Similarly, resveratrol isolated from Vitis vinifera L. was highly effective at 10 and 20 lM, while the commercial Chen et al. (2006) molecule was active at 50 lM. Moreover, carnosic acid obtained from R. officinalis was effective at 10, 20, and 30 lM, while the commercial one was active at 50 lM. In the same line, the phenylethanoid glycosides, acteoside, and oraposide were also more effective when derived from natural sources (8.9 and 3.6 lM) in comparison with the commercial molecules (>200 lM). Finally, salidroside isolated from Rhodiola sachalinensis A. Bor was effective at 1; 5; 10; 50 lg/Ml, while the commercial molecules were effective at 3; 15; 30 lg/mL.
In summary, plant-food-derived bioactive molecules appear to be more effective than the commercial ones; notwithstanding, further studies are necessary to confirm this. Besides, the confirmation of the effective neuroprotective potential needs to be performed, mainly by in vivo studies, once numerous biochemical parameters influence the final bioactivity and active concentrations. Tables 6 and 7 show, respectively, bioactive molecules from commercial and plant origins with reported in vivo neuroprotective effects. Comparing with the previously discussed in vitro neuroprotective effects, only commercial quercetin, ferulic acid, genistein, and hyperforin and bisdemethoxycurcumin, curcumin, demethoxycurcumin, 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose, and 2,3-dihydroxy-4-methoxyacetophenone from plant food origin were also evaluated. Higher concentrations were necessary to obtain the same effect on in vivo experiments. For example, hyperforin at 1 lM was effective under an in vitro model, while 6 lM was the active concentration in the in vivo experiment. Additionally, when compared with the in vitro reports, in vivo studies are significantly scarce. But despite this limitation, the obtained achievements need to be highlighted in order to systematize the knowledge on this area. Phenolic compounds seem to be the most studied phytochemicals regarding neurocognitive benefits. The effects of flavonols have been evaluated using both commercial and plant-origin molecules; flavones, hydroxycinnamic acids, and isoflavones were only studied in commercial forms, while anthocyanins and tannins were obtained from natural extracts (Vitis vinifera L. and Paeonia suffruticosa Andr., respectively). Commercial terpenes and phenylpropanoids, and curcuminoids and other plant-origin biomolecules were also investigated for neuroprotective effects.
Bioactive Compounds with In Vivo Neuroprotective Activity
Rats and mice, followed by wild-type adult zebra fish and Drosophila melanogaster, including species with induced genetic variations, have been the most frequent animal models used. According to the selected animal model, several active concentrations for each bioactive molecule have been observed. Moreover, none of the studied bioactive molecules were evaluated from both commercial and plant-origin sources, being difficult to make comparisons of their effectiveness/efficiency. Among the tested commercial flavones, luteolin showed a dose-dependent effect, mainly acting as downregulator of NF-Kb and BACE-1, and decreased Ab deposition (Fu et al. 2014 ). On the other hand, by using a standard concentration of 50 mg/kg b.w., Richetti et al. (2011) observed that both flavonols, quercetin and rutin, were able to prevent memory and cognitive impairments. Similarly, Mori et al. (2013) observed that ferulic acid (30 mg/kg b.w.) reversed transgene-associated behavioral deficits and decreased brain parenchymal and cerebral vascular b-amyloid deposits and also hyperforin at 6 µM (Dinamarca et al. 2006) . Moon et al. (2014) proved that the phenylpropanoid, 6-shogaol, at 10 mg/kg b.w. was effective in reducing microgliosis and astrogliosis, ameliorating AbO 1-42induced memory impairment and elevating NGF levels, and also pre-and postsynaptic markers. In the same line, Bagheri et al. (2012) observed that genistein at the same concentration (10 mg/kg b.w.) leads to a significant inhibition of neurodegeneration and Ab 1-40 -positive aggregate formation, alleviating consequently extensive astrogliosis. The hydroxycinnamic acid, 3,5-di-caffeoylquinic acid (6.7 mg/kg b.w.), also showed a pronounced effect, being able to decrease in a significant manner escape latency time, by increasing PGK1 and mRNA expression, and also ATP production (Han et al. 2010) .
In relation to plant-origin bioactive molecules, all of them were able to prevent memory and cognitive impairments, in different proportions. For example, anthocyanins from Vitis vinifera L. fruits extract (200 mg/kg b.w.) exerted beneficial effects mainly by preventing scopolamine-induced neurotoxic effects (Gutierres et al. 2014) , while curcuminoids (bisdemethoxycurcumin, curcumin, and demethoxycurcumin) from Curcuma longa L. rhizomes extract, at the concentration of 1 mM, rescued morphological defects on Drosophila melanogaster improving the movement coordination (Wang et al. 2014b) . In a similar manner, kaempferol (12 and 24 ppm), 1,2,3,4,6-penta-O-galloyl-b-D-glucopyranose (8 mg/kg b.w.), and 2,3-dihydroxy-4-methoxyacetophenone (50 mg/kg b.w.) obtained, respectively, from Brassica oleraceae var. gemmifera, Paeonia suffruticosa Andr., and Cynanchum paniculatum (Bunge) Kitag. markedly reduced escape latency time: the first one by its contribution on the reduction in ROS production and consequently improvement in step-through latency time (Kim et al. 2013 ), the second one through the inhibition of Ab fibril formation as also destabilization of the preformed Ab fibrils (Fujiwara et al. 2009) , and the last one, related to NMDA receptor inhibition and breakdown of AChE (Weon et al. 2013 ).
The above-described neuroprotective benefits, both in vivo and in vitro, incite the future use of bioactive molecules from plant food origin as leaders to the AD treatment. It is also important to highlight that despite its neuroprotective and preventive effects, and even treatment/alleviation of the symptomatic conditions, these phytochemicals also possess an interesting and underexplored neuroregenerative potential, which needs to be studied in detail.
Plant Food Bioactive Molecules with Neuroregenerative Activity
Bioactive Compounds with In Vitro Neuroregenerative Activity
In addition to the previously stated promissory neuroprotective benefits of plant food bioactive constituents, its neuroregenerative effects have also been studied, but still have a low progression. Figures 1 and 2 show plant-origin bioactive molecules with prominent in vitro neuroregenerative potential, while Fig. 3 shows results of commercial molecules. Once again, is clearly evident the scarcity of the studied plant species: Cinnamomum cassia Blume, Coptis chinensis Franch., Pueraria montana (Lour.) Merr. var. lobata (Willd.) Maesen & Almeida, Salvia miltiorrhiza Bunge and Scutelaria baicalensis Georgi (Fig. 1) , and Zingiber purpureum Roscoe. Figure 2 shows the currently recognized sources of bioactive molecules with in vitro neurodegenerative benefits. In particular, baicalein, cinnamic acid, epiberberine, genistein, tanshinone IIA, and wogonin, at low concentrations (0.1, 0.3, and 1 µM), evidenced to act synergistically on the brain-derived neurotrophic factor (BDNF) release, mRNA, and protein expression, mainly by phosphorylation of extracellular signal-regulated kinase (ERK) and cyclic AMP element-binding protein (CREB), and inhibition of inducible nitric oxide synthase (iNOS) upregulation. Jeon et al. (2010) clarified those effects by using cortex cerebral cells from fetal Sprague-Dawley rats. On the other hand, Matsui et al. (2012) by using PC12 cells observed that both isolated phenylbutanoid dimers from Z. purpureum (Fig. 2) were able not only to induce neurite sprouting (10-30 µM), but also to confer a significant protection against cell death (3-30 µM). Furthermore, the authors observed a pronounced induction of the number and length of neurites (0.03-3 µM) by using primary cortical neurons of rats. Apart from the studied plant food molecules, several commercial biomolecules were also investigated, mainly in what concerns to the ability to restore mitochondrial functions and reduce Ab production ( Fig. 3) . In general, phenolic compounds were the most frequently studied biomolecules toward to assess mitochondrial function restauration ability, while saponins have been studied to determine the effect on Ab production. Indeed, and as previously mentioned, phenolic compounds are widely recognized for their antioxidant potential (mainly as free radical scavengers, metal quenchers, and hydrogen donators) (Heim et al. 2002; Grotewold 2006; Li et al. 2014) . Commonly known as "powerhouse of the cells," "ATP reservoir" or "energetic factory," mitochondria contribute not only to the proper cellular function, but also to an intensive free radical production (one of the most important endogenous sources of ROS). In fact, brain cells need a higher and continuous demand for energy supply (Chaturvedi and Beal 2013) . Therefore, it is of the utmost importance not only to ensure a proper neuronal function, but also to avoid cellular damages, by discovering new and effective alternatives to restore the optimum mitochondrial functions (in case of injuries). Taking into account those features, several biomolecules have been intensively investigated. It should be pointed that, by itself, a free radical overproduction is not only a triggering factor to AD development, but also promotes Ab production, which leads to an intense organic dysfunction and inflammation. As shown in Fig. 3, flavanones (hesperitin,  naringenin) , flavan-3-ols (catechin, EGCG), flavones (acacetin, aminoflavone, apigenin, baicalein, chrysin, diosmetin, diosmin, luteolin, methoxyflavone, and methylflavone), flavonols (quercetin), and phenolic acids (ferulic acid, methyl cinnamate, and methyl gallate) are among the most prominent phenolic compounds with mitochondrial function restauration ability, at the concentration of 1 µM, in murine neuroblastoma N2a cells. To evaluate the potential of those molecules, Dragicevic et al. (2011) used the levels of ROS, MMP, and ATP as positive indicators.
On the other hand, Chen et al. (2006) observed that saponins, at the final concentration of 50 µM, exerted considerable effects on Ab40 (ginsenoide Rb1, panaxadiol) and Ab42 (ginsenoide Rg1, pseudoginsenoside F11) and also on Ab40 and Ab42 (ginsenoide Rb2, Re, Rg3; notoginsenoside R1) reduction, by using CHO 2B7 cells. In spite of the great interest of these results, further studies are necessary to assess the in vivo effects, including security (mainly to saponins, which depending to the used doses, are often slightly toxic) and bioavailability, and also to establish the therapeutic doses.
Bioactive Compounds with In Vivo Neuroregenerative Activity
Figures 4 and 5 show the in vivo neuroregenerative effects of bioactive molecules from plant and commercial origins, respectively. Among the bioactive molecules from plant origin, only individual phytochemicals obtained from Magnolia officinalis Rhed and Zingiber purpureum Roscoe were evaluated (Fig. 4) . M. officinalis lignans presented the better effect, namely honokiol (1 mg/kg b.w.) and magnolol (10 mg/kg b.w.) (Matsui et al. 2009 ), on the prevention of learning and memory impairments, age-related cholinergic deficits, as also on the improvement in Akt phosphorylation in SAM8 mice forebrain. The phenylbutanoid dimers (50 mg/kg b.w.) appear as the great contributors to OBX mice BrdU/NeuN double-labeled cell improvement (Matsui et al. 2012) . In general, the authors concluded that the mentioned phytochemicals possess promissory neurotrophic effects; so, their further investigation is of the utmost importance, to be effectively used, in the near future, to threat and even to modify the course of several neurological disorders. Among the commercial bioactive compounds (Fig. 5) , the flavan-3-ols with a renowned and doubtless antioxidant potential, namely EGCG (37.1 mg/kg b.w.) from green tea (Dragicevic et al. 2011) , were the most studied, and also triterpenoid saponins that include ginsenoside Re, Rg1, and Rg3 (25 mg/kg b.w.) (Chen et al. 2006 ).
In the first case, EGCG was able to improve the activity of a-secretase and to reduce brain mitochondrial Ab and AbPP levels in AbPP/PS1 double-mutant transgenic mouse models. Otherwise, ginsenoside Re, Rg1, and Rg3 evidenced a higher potential to reduce not only Ab42, but also Ab40 brain levels in Tg2576 female transgenic mice models that overexpress the human APP gene.
Overall, and despite the described effects of the tested bioactive components, it is difficult to compare their efficacy and also efficiency once different biochemical parameters were assessed, and also biological antineuronal damage effects.
Neuromodulation and Neuroplasticity: Future Trends
to an Optimum Brain Health
The in vitro and in vivo promissory neurocognitive benefits evidenced by plant products clearly point to an upcoming approach as future leaders on neurodegenerative diseases. In particular, their neuroprotective effects are pivotal once prevention comprises one of the most important key points on integrative intervention. Notwithstanding, in some cases, considerable changes on learning and memory abilities, and also lagged perceptions and neuronal losses, are found, which requires a therapeutic intervention (van Praag 2009; Essa et al. 2012; Yoo and Park 2012; Ahmed et al. 2015) . Otherwise, along with the disseminated idea that brain cells (such as neurons, microglia, and other glial cells) are not able to regenerate, increasing evidences have shown that they possess an interesting ability to synapse remodeling and consequently to recover its synaptic plasticity, neuronal spine density, and, therefore, cognitive improvement. Numerous signaling molecules, transporters, and codifying proteins, genes, and so on are involved on the mentioned complex process (McCoy et al. 2009; van Praag 2009; Nadim and Bucher 2014; Wester and McBain 2014) . Plant-derived bioactive molecules, and also physical exercise, have shown to act as important contributors, once rest neurodegeneration, and improve neuroregenerative processes (van Praag 2009). In spite of their pivotal biological interests, the neuromodulatory and neuroplasticity abilities of numerous bioactive molecules remain poorly investigated, as also the involved modes of action. For example, it is convenient to highlight that 2,3,5,4′-tetrahydroxystilbene-2-O-b-Dglucoside (TSG), a phenolic compound derived from Polygonum multiflorum Thunb., evidenced potent cognitive improving and hippocampal synaptic plasticity promoting (Wang et al. 2011) abilities: facilitates the induction of hippocampal long-term potentiation (LTP) through activation of postsynaptic signal molecules and other signalling pathways, which contributes to the in vivo improvement of learning behavior, memory, and neuronal networks in rats. Liang et al. (2014) also showed that dihydromyricetin (DHM), a flavonoid compound, restores gephyrin (a postsynaptic anchor protein at GABAergic synaptic sites) levels, when administered in mouse models with AD. Gephyrin is directly involved on GABA receptor functioning, once regulates its formation, plasticity and availability, as also from other signalling molecules (Liang et al. 2014 ). Furthermore, Zhan et al. (2014) observed that berberine, a plant alkaloid, was able to reverse synaptic deficits induced by D-galactose and rescued important intermediates (mRNA, Arc/Arg3.1) directly involved on normal synaptic plasticity.
Otherwise, and in association with the previous stated effects, it is also important to point out that hypothalamic neuromodulator systems are also affected/affect daily energy homeostasis. For example, under specific conditions (such as short-term fasting and other metabolic state changes), considerable synaptic circuits and respective (inter)neuronal controllers suffer from restructuration, which leads to physiological variations on energy homeostasis and may cause synaptic plasticity impairments (Horvath 2006) . Thus, the above-described mechanisms of action of bioactive molecules can be also extremely useful in other contexts, such as feeding and appetite controllers. For example, plant-derived cannabinoids (phytocannabinoids) and endocannabinoids, in spite of the whole negative connotation attributed to cannabis, have shown greater contributive properties not only for physiological appetite and satiety controllers (Berry and Mechoulam 2002) , but also for brain therapeutical purposes (i.e., neuromodulators, neuroprotective, neuroregenerative, and synapsis plasticity regulators) (Fisar 2009 ).
